Ischaemia-Driven Optimal Therapeutic Approach in Asymptomatic Patients with High Cardiovascular Risk: The Value of Clinical, Laboratory and Myocardial Spect Imaging Findings

Abstract Background: We wanted to evaluate the presense of myocardial ischaemia in asymptomatic patients with high cardiovascular risk, the influencing clinical and laboratory factors and the impact of ischaemia on final management decision. Material and methods: We evaluated 60 asymptomatic patients with high CV risk, who underwent SPECT myo-cardial perfusion imaging (MPI) for detection of suspected CAD. We used the 17 segment model for quantitative and semiquantitative scan perfusion and function analysis using perfusion scores. All patients had full blood laboratory analyses including lipid values, presence of albuminuria, rest and stress ECG. Logistic regression analysis was used to assess the impact of clinical and laboratory parameters on myocardial ischaemia prevalence. Results: Stress-inducible ischaemia was found in 19 pts (33%), fixed defects were found in 13% and mixed defects in 9% of cases. The average ischaemia amount was 10%. Mild ischaemia was found in 12 patients (64%) - summed stress score (SDS) < 4, moderate ischaemia in 5 patients (26%) - SDS 5-7 and severely abnormal scans in 2 patients (10%) - SDS > 7. Severe ischaemia was only related to the duration of diabetes. Six pts with severe ischaemia had ST depression > 2 mm on stress study, and a higher wall motion index and LVEF fall > 5% during stress study (p < 0.01). Stepwise logistic regression analysis for prediction of stress-induced ischaemia showed OR 2.4 (95% CI 1.7?3.6) for stress-induced ECG changes and OR 3.9 for presence of DM over 10y (95% CI 2.3?6.6). Seven patients with ischaemia > 10%, were referred for coronary angiography. Conclusions: MPI is a valuable method for preclinical assessment of myocardial ischaemia in patients with high CV risk, which can improve prognosis and guide treatment decision.

[1]  Shah Ebrahim,et al.  European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.

[2]  G. Beller,et al.  Stress myocardial perfusion imaging for assessing prognosis: an update. , 2011, JACC. Cardiovascular imaging.

[3]  Erling Falk,et al.  Why not screen for subclinical atherosclerosis? , 2011, The Lancet.

[4]  M. Budoff,et al.  2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2010, Circulation.

[5]  P. Shah Screening asymptomatic subjects for subclinical atherosclerosis: can we, does it matter, and should we? , 2010, Journal of the American College of Cardiology.

[6]  V. Fuster,et al.  The CVD paradox: mortality vs prevalence , 2009, Nature Reviews Cardiology.

[7]  Jeroen J. Bax,et al.  Early detection of coronary heart disease in diabetic patients without symptoms of coronary artery disease: implications for expanded use of myocardial perfusion imaging , 2005 .

[8]  M. D. Di Carli,et al.  Should we screen for occult coronary artery disease among asymptomatic patients with diabetes? , 2005, Journal of the American College of Cardiology.

[9]  R. Gibbons,et al.  Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging. , 2005, Journal of the American College of Cardiology.

[10]  E. Barrett,et al.  Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. , 2004, Diabetes care.

[11]  R. Gibbons,et al.  Yield of stress single-photon emission computed tomography in asymptomatic patients with diabetes. , 2004, American heart journal.

[12]  D. Berman,et al.  Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients. , 2004, European heart journal.

[13]  L. Shaw,et al.  Prognostic value of gated myocardial perfusion SPECT , 2004, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[14]  A. Siqueira-Filho,et al.  Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease. , 2002, The American journal of cardiology.

[15]  D. Berman,et al.  Comparative ability of myocardial perfusion single-photon emission computed tomography to detect coronary artery disease in patients with and without diabetes mellitus. , 1999, American heart journal.

[16]  L. Shaw,et al.  2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2010, Circulation.

[17]  R. Ferrari,et al.  Cardiovascular Disease Prevention in Clinical Practice , 2010 .

[18]  S. Abraham,et al.  22. Observer variation in electrocardiographic interpretation , 1964 .